TSX:GUD (Knight Therapeutics Inc.)
About GUD
Knight Therapeutics Inc is a specialty and generic drug manufacturing company. The company's principal business activity is focused on developing, acquiring, in-licensing, out-licensing, marketing, and distributing innovative pharmaceutical products, consumer health products, and medical devices in Canada and select international markets. Knight finances other life sciences companies across the globe in order to generate interest income, strengthen relationships in the life sciences industry, and to secure product distribution rights.
Knight Therapeutics Inc. (TSX: GUD) Latest News

Investing
4 Biotech Stocks That Could Break Through the Market

Dividend Stocks
3 Biotech Stocks to Buy Before the Down Market Is Over

Investing
This Biotech Stock Could Offer Big Growth – Even During a Recession

Stocks for Beginners
2 Health Care Stocks Could Return at Least 50% in 1 Year

Investing
Can the Healthcare Sector Rebound in 2022?

Investing
Strong Buy Ratings: 2 Healthcare Stocks With More Than 40% Upside

Coronavirus
Forget Trillium Therapeutics Stock (TSX:TRIL): Buy These Pharma Stocks Instead!

Investing
TFSA Investors: 1 Low-Risk Value Stock With Significant Upside

Coronavirus
Got $3,000? 3 Dirt-Cheap TSX Stocks to Buy Today

Dividend Stocks
TFSA: 3 Super Stocks That Can Make You Rich

Investing
Top TSX Stocks Under $10

Coronavirus
2 TSX Pharma Stocks That Can Make You a TFSA Millionaire
1❯